Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis

@article{Rossetter2015BenzodiazepinesFP,
  title={Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis},
  author={Sarah R Rossetter and Bethany J. DeRHODES and Randon S. Welton},
  journal={Journal of Psychiatric Practice},
  year={2015},
  volume={21},
  pages={281–303}
}
Objective: Although benzodiazepines (BZDs) are commonly used in the treatment of posttraumatic stress disorder (PTSD), no systematic review or meta-analysis has specifically examined this treatment. The goal of this study was to analyze and summarize evidence concerning the efficacy of BZDs in treating PTSD. Methods: The review protocol was undertaken according to the principles recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and is… 
Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study
TLDR
Sertraline showed greater efficacy in enhancing Impact of Event Scale-Revised and Clinical Global Impression Scale-Severity scores at 6 and 12 weeks relative to that of the placebo and was efficacious and well-tolerated in Chinese patients with PTSD.
An Emulation of Randomized Trials of Administrating Benzodiazepines in PTSD Patients for Outcomes of Suicide-Related Events
TLDR
Certain benzodiazepines may provide a reduced risk of development of SRBs, suggesting careful consideration when prescribing benzodiazines to the PTSD population.
Exposure therapy for PTSD: A meta-analysis.
TLDR
The overall efficacy of exposure therapy for PTSD is examined and it is highlighted that there are a number of efficacious exposure-based therapies available.
Mental health interventions following COVID-19 and other coronavirus infections: a systematic review of current recommendations and meta-analysis of randomized controlled trials
TLDR
A systematic review of the literature assessing three databases found a large body of expert recommendations that may help health practitioners, institutional and governmental leaders, and the general population cope with mental health issues during a pandemic or a crisis period, but most articles had a low level of evidence.
Serotonergic Synergy in the Pharmacotherapy of Acute Posttraumatic Stress Disorder Exacerbation: A Case Report.
TLDR
A case of combat-related PTSD with severe panic, suicidality, and agitation which responded favorably to a combination of ziprasidone, propranolol, and hydroxyzine, which may be potential alternatives for anxiolytics like benzodiazepines.
Pharmacotherapeutic considerations for the treatment of posttraumatic stress disorder during and after pregnancy
TLDR
Clinical studies and consensus guidelines in the treatment of perinatal PTSD are needed given the high prevalence of the disorder and the significant risks associated with inadequate treatment.
Considering future pharmacotherapy for PTSD
TLDR
Why it has taken so long to identify important targets to advance the field by addressing the underlying pathophysiology in pharmacological interventions is considered and why there are many unanswered questions is considered.
Physical Activity in People With Posttraumatic Stress Disorder: A Systematic Review of Correlates.
TLDR
Hyperarousal symptoms are associated with lower physical activity participation among people with PTSD and should be considered in the design and delivery of individualized exercise programs targeting this population.
Posttraumatic Stress Disorder Risk and Benzodiazepine Dependence in Older Veterans with Insomnia Symptoms.
TLDR
In older veterans with insomnia symptoms and chronic use of BZAs, high PTSD risk is associated with elevated risk for BZA dependence, which may make discontinuation of these medications difficult.
Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
TLDR
Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation, and both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 56 REFERENCES
Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review
TLDR
The non-antidepressant agent with the strongest scientific evidence supporting its use in PTSD is risperidone, which can be envisaged as an effective add-on therapy when patients did not fully benefit from previous treatment with SSRIs.
Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder?
TLDR
Prolonged exposure is a sufficiently robust treatment that patients who are taking benzodiazepines can benefit from it, andBenzodiazepine recipients' poorer maintenance of gains in present-centered psychotherapy is identified.
Posttraumatic stress disorder in general intensive care unit survivors: a systematic review.
TLDR
The prevalence of PTSD in ICU survivors is high and negatively impacts survivors' HRQOL, and future studies should comprehensively address how patient-specific factors relate to one another and to post-ICU PTSD.
Pharmacotherapy for posttraumatic stress disorder: review with clinical applications.
TLDR
The pharmacotherapy recommendations from the 2010 revised Department of Veterans Affairs/Department of Defense Clinical Practice Guideline for PTSD are reviewed and practical PTSD treatment recommendations for clinicians are provided.
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
TLDR
The early administration of benzodiazepines to trauma survivors with high levels of initial distress did not have a salient beneficial effect on the course of their illness, while reducing physiologic expression of arousal.
Clonazepam for Treatment of Sleep Disturbances Associated with Combat-Related Posttraumatic Stress Disorder
TLDR
Clonazepam therapy was largely ineffective in improving sleep disturbances, particularly nightmares, associated with combat-related PTSD, and further studies are needed to further define the role of this widespread clinical practice.
Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.
TLDR
Although use targeted specifically to PTSD and to comorbid disorders was common, substantial use appeared to be unrelated to diagnosis and may be targeted at specific symptoms rather than diagnosed illnesses.
Effects of the benzodiazepine antagonist flumazenil in PTSD
TLDR
Flumazenil administration does not produce an increase in anxiety and PTSD symptoms in patients with PTSD, which suggests that PTSD and panic disorder are dissimilar in terms of benzodiazepine/GABAA system function.
Patient and facility characteristics associated with benzodiazepine prescribing for veterans with PTSD.
TLDR
Interventions could be designed to target individual high-volume prescribers or influence prescribing culture at the facility level to ensure consistent access to guideline-concordant PTSD treatment across the VHA.
Substance use disorders in patients with posttraumatic stress disorder: a review of the literature.
TLDR
Vigorous control of withdrawal and PTSD-related arousal symptoms should be sought during detoxification of patients with comorbid PTSD and substance use disorders.
...
1
2
3
4
5
...